Panel, Conference Presentation
Advancing Health Technology and Innovation
Milken InstituteJonathan Simons, Chris Austin, Annalisa Jenkins, Richard Merkin, Kim Nguyen, David Spetzler
- Genomics and editing technologies like CRISPR are projected to transform healthcare into precise treatment protocols, potentially rendering currently incurable diseases obsolete and relegating fatal conditions to history.
- Specific technological interventions include implantable devices to monitor glaucoma pressure over weeks, the use of edited animal organs to resolve transplant shortages, and food production improvements via CRISPR.
- Rare disease diagnosis timelines are expected to shrink from eight to ten years to one year by the end of the next decade, coinciding with a projection of 1,000 new rare disease drug developments over the subsequent ten years.
- Machine learning systems are anticipated to interpret medical imaging (X-rays, CTs, MRIs, mammograms) with error rates lower than human specialists, performing at a cost of $0.002 compared to $50 for human interpretation.
- Blockchain technology is expected to streamline healthcare finance by eliminating exchange fees and automating accounting, billing, and payments through smart contracts.
- Patient strategies utilizing genomic understanding aim to significantly extend lifespans while reducing the average number of therapy lines required per patient.
- Investment and research will focus on the cardiovascular space to understand inflammatory mediators in atheromatous plaque, alongside new commercial models to fund drug repurposing for extended life.
- Microbiome research targeting specific polysaccharides aims to eventually enable treatments for Alzheimer's and similar conditions, with the broader goal of creating watchable, functional medicines.
- A strategic focus on a tenfold improvement mindset rather than incremental gains is expected to democratize precision medicine across the sector.
- Market conditions are characterized as optimal for investors, academics, and medical professionals, with capital flows expected to be driven by a combination of creative ideation, risk capital, and human capital in the UAE.